FDA
- Marketing authorisation holder: LILLY
- Status: approved
🇺🇸 Dicurin Procaine in United States
Dicurin Procaine (MERETHOXYLLINE PROCAINE) regulatory status in United States.
Marketing authorisations
FDA
- Application: NDA008869
- Marketing authorisation holder: LILLY
- Local brand name: DICURIN PROCAINE
- Indication: INJECTABLE — INJECTION
- Status: approved
Dicurin Procaine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Dicurin Procaine approved in United States?
Yes. FDA has authorised it; FDA has authorised it.
Who is the marketing authorisation holder for Dicurin Procaine in United States?
LILLY holds the US marketing authorisation.